Testing effectiveness (Phase 2)Not Yet RecruitingNCT07530224
What this trial is testing
JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis
Who this might be right for
Immune Checkpoint Inhibitor-Induced Dermatitis
Shixiu Wu 35